These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1719730

  • 21. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P, Bilek M, Tekusch A.
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
    Müller-Bühl U, Comberg HU, Diehm C, Allenberg J, Mörl H.
    MMW Munch Med Wochenschr; 1982 Mar 12; 124(10):241-3. PubMed ID: 6178019
    [No Abstract] [Full Text] [Related]

  • 25. Placebo-controlled, double-blind study of haemodilution in peripheral arterial disease.
    Ernst E, Matrai A, Kollar L.
    Lancet; 1987 Jun 27; 1(8548):1449-51. PubMed ID: 2885450
    [Abstract] [Full Text] [Related]

  • 26. Haemodilution in patients with peripheral arterial occlusive disease.
    Kiesewetter H, Jung F, Erdlenbruch W, Wenzel E.
    Int Angiol; 1992 Jun 27; 11(3):169-75. PubMed ID: 1281205
    [Abstract] [Full Text] [Related]

  • 27. The effect of hemodilution upon patients with intermittent claudication.
    Wolfe JH, Waller DG, Chapman MB, Blackford HN, Prout WG.
    Surg Gynecol Obstet; 1985 Apr 27; 160(4):347-51. PubMed ID: 2580361
    [Abstract] [Full Text] [Related]

  • 28. [Effect of 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on the flow property and coagulation of whole blood in vivo].
    Klose R, Feldmann U, Hoecker P.
    Infusionsther Klin Ernahr; 1987 Apr 27; 14 Suppl 2():37-42. PubMed ID: 2439457
    [Abstract] [Full Text] [Related]

  • 29. [Rheologic effects of normovolemic hemodilution].
    Kuznetsov NA, Aleksandrova NP, Bogdanov AE, Rogulenko RV.
    Anesteziol Reanimatol; 1990 Apr 27; (2):18-22. PubMed ID: 1698041
    [Abstract] [Full Text] [Related]

  • 30. Hematocrit as a risk factor for vascular disease.
    Kiesewetter H, Jung F, Lazar H, Roggenkamp HG, Leipnitz G, Kiehl R.
    Klin Wochenschr; 1986 Oct 01; 64(19):974-8. PubMed ID: 3784450
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Hemodilution, hemorheology and oxygen supply].
    Ehrly AM.
    Acta Med Austriaca; 1991 Oct 01; 18 Suppl 1():3-8. PubMed ID: 1950386
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Hematocrit dependent changes of muscle tissue oxygen supply in the lower limb muscle of patients with intermittent claudication.
    Höffkes HG, Ehrly AM.
    Vasa; 1992 Oct 01; 21(4):350-4. PubMed ID: 1485467
    [Abstract] [Full Text] [Related]

  • 37. [Treatment of apoplexy with hypervolemic hemodilution].
    Kabus C, Semler P.
    Z Arztl Fortbild (Jena); 1992 Dec 22; 86(23-24):1153-60. PubMed ID: 1283649
    [No Abstract] [Full Text] [Related]

  • 38. [Conservative therapy of peripheral arterial occlusive diseases].
    Alexander K.
    Z Kardiol; 1993 Dec 22; 82 Suppl 5():89-98. PubMed ID: 8154166
    [Abstract] [Full Text] [Related]

  • 39. [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].
    Haass A, Kroemer H, Jäger H, Müller K, Decker I, Wagner EM, Schimrigk K.
    Dtsch Med Wochenschr; 1986 Oct 31; 111(44):1681-6. PubMed ID: 2429818
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.